XML 16 R25.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Loss Per Share (Tables)
 6 Months Ended
Jun. 30, 2015
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following tables reconcile the components of the numerator and denominator included in the calculations of diluted loss per share:

Three Months Ended June 30,

2015

2014
Numerator



Net loss attributable to Inovio Pharmaceuticals, Inc.
$
(6,248,250
)

$
(10,711,274
)
Reflect adjustment for decrease in fair value of warrant liability
(22,727
)

(873,389
)
Numerator for use in diluted loss per share
$
(6,270,977
)

$
(11,584,663
)




Denominator



Weighted average number of common shares outstanding
67,655,975


60,232,498

Effect of dilutive potential common shares from warrants
182,763


242,361

Denominator for use in diluted loss per share
67,838,738


60,474,859


 
 
 
Net loss per share, diluted
$
(0.09
)
 
$
(0.19
)

 
Six Months Ended June 30,
 
2015
 
2014
Numerator
 
 
 
Net loss attributable to Inovio Pharmaceuticals, Inc.
$
(16,830,029
)
 
$
(21,532,734
)
Reflect adjustment for decrease in fair value of warrant liability
(312,500
)
 
(615,684
)
Numerator for use in diluted loss per share
$
(17,142,529
)
 
$
(22,148,418
)
 
 
 
 
Denominator
 
 
 
Weighted average number of common shares outstanding
64,198,528

 
57,722,938

Effect of dilutive potential common shares from warrants
177,995

 
253,517

Denominator for use in diluted loss per share
64,376,523

 
57,976,455

 
 
 
 
Net loss per share, diluted
$
(0.27
)
 
$
(0.38
)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table summarizes potential common shares that were excluded from the diluted net loss per share calculation because of their anti-dilutive effect:
 
As of June 30,
Common Stock Equivalents
2015
 
2014
Options to purchase common stock
5,987,210

 
4,943,567

Warrants to purchase common stock
627,969

 
1,085,386

Restricted stock units
230,000

 
—

Convertible preferred stock
8,456

 
8,456

Total
6,853,635

 
6,037,409